Indian employees can anticipate salary increments of 8.6% to 10.2% in FY2026-27, with EV infrastructure, fintech, and healthcare sectors le...

State Bank of India is set to commit up to $1 billion to fund Sun Pharmaceutical Industries Ltd.'s $12 billion acquisition of Organon & Co....

Assam Chief Minister Himanta Biswa Sarma met the "Team Europe" EU delegation to boost trade and investment. The two-day visit focuses on se...

Corporate India anticipates salary increments between 8.6% and 10.2% this financial year, driven by demand for skilled talent in high-growt...

India is ready to welcome high-quality global pharmaceutical products. This move is in exchange for better market access for Indian drug ex...

Indian companies have invested close to CAD 11 billion in Canada. These investments span various sectors, creating over 33,000 jobs. Indian...

Even in normal times it is futile to try and guess the outcome of most global events. But in the New World Order, it makes no sense at all ...

India's drug pricing authority may soon approve a price hike for vital platinum-based cancer medicines. These drugs, including carboplatin ...

Uzbekistan is inviting Indian drug companies to invest more. They are offering better subsidies and technology help. This aims to make Uzbe...

In a bold move towards self-sufficiency, India is ramping up its domestic manufacturing initiatives! Six government-led teams are tasked wi...

India's drug regulator, CDSCO, has mandated all drug companies to establish systems for tracking adverse drug reactions. This move comes am...

India is boosting domestic manufacturing. Six expert groups will identify 100 products to reduce import dependence. This initiative aims to...

Venezuela's acting President Delcy Eloina Rodriguez Gomez is in India for a five-day visit. She will meet Prime Minister Narendra Modi. The...

Indian pharma exports to the US face a subdued outlook this year. Policy uncertainties, falling generic prices, and regional conflicts are ...

Pharma industry officials say the revised Schedule M regulations could require Rs 10-15 crore per facility in upgrades, while talent shorta...

Wockhardt's novel antibiotic, Zaynich, has received USFDA approval after a 12-year effort, sparking hopes for a turnaround after years of n...

There was a time when the Indian pharma story in the US was almost entirely about inspection risk. The US FDA would inspect a plant, a warn...